Wednesday, July 8, 2026

pharma · Dermatomyositis · Diffuse Cutaneous Systemic Sclerosis · CRBP

Corbus Pharmaceuticals

Corbus Pharmaceuticals trial registry — 11 ClinicalTrials.gov studies with program phase, status, and indication context.

500 River Ridge Dr, Norwood, Massachusetts 02062, US HQ
2014 Founded
57 Employees
Public company Type
CRBP · NYSE Ticker
Company details
Status
Public
HQ
500 River Ridge Dr, Norwood, Massachusetts 02062, US
Founded
2014
Employees
57
Programs
11
Drugs
3
Patents
6
Intelligence · Clinical Trials

Corbus Pharmaceuticals clinical trials

Registry index of 11 ClinicalTrials.gov studies linked to Corbus Pharmaceuticals programs — each row shows trial ID, program name, phase, status, and indication.

Corbus Pharmaceuticals trial registry — 11 ClinicalTrials.gov studies with program phase, status, and indication context.

Recent trial activity

8 updates

Latest clinical program signals indexed for Corbus Pharmaceuticals.

  1. JBT-101 — Phase 2

    Clinical update
  2. CRB-601 monoclonal antibody — Phase 2

    Clinical update
  3. A Clinical Trial for Patients with Advanced Cancers — Phase 2

    Clinical update
  4. Lenabasum 20 mg — Phase 3

    Clinical update
  5. Lenabasum 5 mg — Phase 3

    Clinical update
  6. CRB-701 — Phase 2

    Clinical update
  7. JBT-101 — Phase 2

    Clinical update
  8. JBT-101 — Phase 2

    Clinical update

Trial registry

11 studies